Strength |
Quality of Evidence |
Rating |
Definition |
Rating |
Definition |
A |
Strong |
1 |
Based on published results of at least 1 randomized clinical trial with clinical outcomes or validated laboratory endpoints. |
B |
Moderate |
* |
Based on either a self-evident conclusion; conclusive, published, in vitro data; or well-established practice that cannot be tested because ethics would preclude a clinical trial. |
C |
Optional |
2 |
Based on published results of at least 1 well-designed, nonrandomized clinical trial or observational cohort study with long-term clinical outcomes. |
|
2† |
Extrapolated from published results of well-designed studies (including nonrandomized clinical trials) conducted in populations other than those specifically addressed by a recommendation. The source(s) of the extrapolated evidence and the rationale for the extrapolation are provided in the guideline text. One example would be results of studies conducted predominantly in a subpopulation (e.g., one gender) that the committee determines to be generalizable to the population under consideration in the guideline. |
3 |
Based on committee expert opinion, with rationale provided in the guideline text. |